Havencrest Healthcare Partners Amends Oncology Institute Stake

TL;DR

Havencrest Healthcare Partners updated its 13D filing for Oncology Institute, Inc. with new group members.

AI Summary

Havencrest Healthcare Partners, L.P. filed an amendment (No. 5) to its Schedule 13D on August 20, 2024, regarding its beneficial ownership of The Oncology Institute, Inc. The filing indicates a change in the group members, with Havencrest Healthcare Partners GP, LLC and TOI HC I, LLC now listed as group members. This amendment follows a previous name change for the issuer from DFP HEALTHCARE ACQUISITIONS CORP. to The Oncology Institute, Inc. on January 8, 2020.

Why It Matters

This filing signals a potential shift in control or strategy for The Oncology Institute, Inc. by clarifying the entities involved in Havencrest Healthcare Partners' beneficial ownership.

Risk Assessment

Risk Level: medium — Amendments to Schedule 13D filings can indicate changes in significant beneficial ownership, potentially leading to shifts in corporate control or strategy.

Key Players & Entities

• Havencrest Healthcare Partners, L.P. (company) — Filing entity
• The Oncology Institute, Inc. (company) — Subject company
• Havencrest Healthcare Partners GP, LLC (company) — Group member
• TOI HC I, LLC (company) — Group member
• Christopher Kersey (person) — Manager for Havencrest Healthcare Partners
• DFP HEALTHCARE ACQUISITIONS CORP. (company) — Former name of subject company

FAQ

Key Financial Figures

• $0.0001 — of Issuer) Common Stock, par value of $0.0001 per share (Title of Class of Securiti

Filing Documents

• d864423dsc13da.htm (SC 13D/A) — 71KB
• 0001193125-24-203246.txt ( ) — 73KB

From the Filing

SC 13D/A 1 d864423dsc13da.htm SC 13D/A SC 13D/A SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 5)* The Oncology Institute, Inc. (Name of Issuer) Common Stock, par value of $0.0001 per share (Title of Class of Securities) 23343Q100 (CUSIP Number) Christopher Kersey Manager 2100 McKinney Ave, Suite 1760 Dallas, Texas 75201 Tel: (214) 420-3481 (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications) August 16, 2024 (Date of Event which Requires Filing of this Statement) If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box: Note: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See 240.13d-7 for other parties to whom copies are to be sent. * The remainder of this cover page shall be filled out for a reporting persons initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page. The information required on the remainder of this cover page shall not be deemed to be filed for the purpose of Section 18 of the Securities Exchange Act of 1934 (Act) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). (Continued on following pages) Common Stock CUSIP No. 23343Q100 1 NAME OF REPORTING PERSON Havencrest Healthcare Partners, L.P. 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a)(b) 3 SEC USE ONLY 4 SOURCE OF FUNDS OO (see Item 3) 5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e) 6 CITIZENSHIP OR PLACE OF ORGANIZATION Delaware, United NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH 7 SOLE VOTING POWER 0 shares 8 SHARED VOTING POWER (1) 100,000 shares 9 SOLE DISPOSITIVE POWER 0 shares 10 SHARED DISPOSITIVE POWER (1) 100,000 shares 11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON (1) 100,000 shares 12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES 13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) (2) 0.13% 14 TYPE OF REPORTING PERSON PN (1) Consists of 100,000 shares of Common Stock (as defined herein) for which TOI HC I, LLC is the record owner and excludes 3,325,177 Earnout Shares (as defined herein) that may be issued to TOI HC I, LLC pursuant to the Merger Agreement (as defined herein). Havencrest Healthcare Partners, L.P. may be deemed to have beneficial ownership of the shares directly held by TOI HC I, LLC. Havencrest Healthcare Partners GP, LLC controls Havencrest Healthcare Partners, L.P. (2) Based on 75,490,489 shares of Common Stock of the Issuer (as defined herein) outstanding as of August 6, 2024, as reported in the Issuers Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on August 13, 2024. 2 Common Stock CUSIP No. 23343Q100 1 NAME OF REPORTING PERSON Havencrest Healthcare Partners GP, LLC 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a)(b) 3 SEC USE ONLY 4 SOURCE OF FUNDS OO (see Item 3) 5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e) 6 CITIZENSHIP OR PLACE OF ORGANIZATION Delaware, United NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH 7 SOLE VOTING POWER 152,626 shares 8 SHARED VOTING POWER (1) 100,000 shares 9 SOLE DISPOSITIVE POWER 152,626 shares 10 SHARED DISPOSITIVE POWER (1) 100,000 shares 11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON (1) 252,626 shares 12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES 13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) (2) 0.33% 14 TYPE OF REPORTING PERSON OO (Limited Liability Company) (1) Consists of 100,000 shares of Common Stock for which TOI HC I, LLC is the record owner and excludes 3,325,177 Earnout Shares that may be issued to TOI HC I, LLC pursuant to the Merger Agreement. Havencrest Healthcare Partners, L.P. may be deemed to have beneficial ownership of the shares directly held by TOI HC I, LLC. Havencrest Healthcare Partners GP, LLC controls Havencrest Healthcare Partners, L.P. (2) Based on 75,490,489 shares of Common Stock of the Issuer outstanding as of August 6, 2024. 3 Common Stock CUSIP No. 23343Q100 1 NAME OF REPORTING PERSON TOI HC I, LLC 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a)(b) 3 SEC USE ONLY 4 SOURCE OF FUNDS OO (see Item 3) 5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PU

View Full Filing

View this SC 13D/A filing on SEC EDGAR